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IMPACT OF COMPARATIVE EFFECTIVENESS RESEARCH ON BIOMEDICAL 
INNOVATION AND POPULATION HEALTH  
Pritchard DE1, Eber M2, Huesch MD3, Dubois RW1, Lakdawalla D3 
1National Pharmaceutical Council, Washington, DC, USA, 2Precision Health Economics, Los 
Angeles, CA, USA, 3University of Southern California, Los Angeles, CA, USA  
OBJECTIVES: The use of Comparative Effectiveness Research (CER) is intended to 
help patients and providers make sound health care and treatment decisions. 
However, little is known about the impact of CER on financial incentives for 
medical innovation and, ultimately, the health of future generations. Using a 
microsimulation approach, we analyze the impacts of potential CER policies on 
biomedical innovation and population health in the United States and Europe. 
METHODS: We selected three clinical scenarios that reflect broad trends for 
assessing the impacts of CER policies on innovation returns: growth in 
personalized medicine; increasing demand for head-to-head trials; and changes 
in size and complexity of trials. We estimated the impact on development costs, 
revenue, and the timing of returns (lags between development, approval, and 
reimbursement coverage). These scenario-specific impacts were then 
generalized to the US and European markets, and a range of estimated effects of 
CER policies were compiled. We simulated the impact of changes in current 
innovation incentives on producer output and the health of future populations in 
year 2060 using the Future Elderly Model (FEM). RESULTS: Under most scenarios, 
CER policies would have negative impacts on innovation, and lead to substantial 
reductions in population life expectancy. Population life expectancy was 
estimated to be reduced by 14.1% (range, 9.0% to 15.6%) by 2060 due to CER 
policies related to trends in personalized medicine, 4.4% (-8.1% to +5.5%) related 
to active comparators, and 7.4% (-11.4% to +10.2%) related to increased trial 
complexity. Only with multiple innovation-friendly assumptions (such as trial 
cost reductions, relatively high price increases, and large market size growth 
driven by personalized medicine), do CER policies generate increases in 
innovation output and corresponding social value. CONCLUSIONS: The potential 
long-run consequences of CER on innovation and future health calls for careful 
consideration of CER policies that encourage and incentivize innovation.  
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PRESCRIBING PATTERN OF CLINICIANS IN PRIVATE HEALTH FACILITIES: AN 
ASSESSMENT FOR RATIONAL DRUG USE  
Ahmad M1, Akhtar M1, Ahmad I2, Jan SU3 
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OBJECTIVES: The current study was aimed to explore the prescribing pattern of 
clinicians practicing at their private clinics for evaluation of rational drug use. 
METHODS: Eight community pharmacies were selected to collect prescriptions 
randomly and studied for the conformity of the prescriptions issued by clinicians 
with the general format of a typical prescription and rational drug use, following 
WHO guidelines. The four months study was comprised of 1230 total number of 
prescriptions. RESULTS: Majority of the prescriptions did not conform to the 
format of a typical prescription. Twenty three percent (23.2%) of total 
prescriptions were not included the age of the patient out of which were 30.1% of 
pediatric prescriptions. Superscription was not mentioned in 10.9% of the 
prescriptions. Inscription, subscription and signatura were inadequate in 33.4%, 
22.6% and 29.2% of the prescriptions, respectively. Seven percent (7%) of total 
prescriptions were computer generated. The average number of drugs per 
prescription was found to be 3.4. Generic prescribing was very low at 13.5%. 
Antibiotics (39.9%) were the highest prescribed drugs while 
analgesics/antipyretics, antihypertensive, vitamin preparations, antiulcer, 
anxiolytics and antihistaminic were commonly prescribed drugs. About 19.3% of 
the encounters had at least one injection prescribed. More than half (56.2%) of 
the prescribed drugs were from the National Essential Drugs List of Pakistan. 
CONCLUSIONS: A number of prescriptions do not conform to ideal prescribing 
pattern and lack in their rationality. Overuse of antibiotics & injections, small 
number of generic prescribing and polypharmacy were observed in private 
health facilities in Pakistan. The current study can help to recognize the 
dilemma in therapeutic decision making and to improve the prescribing skills by 
planning for educational interventions.  
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PATTERN OF PRESCRIBING: INFORMATION FROM COMMUNITY PHARMACIES IN 
THE PROVINCE OF BASRAH, IRAQ  
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OBJECTIVES: To determine the practice of prescribing medicines by specialized 
physicians in Basrah. METHODS: A drug utilization study was conducted among 
pharmacies’ attendees while purchasing their treatments in Basrah, southern 
governorate of Iraq, from June to August 2011. A stratified sample method was 
adopted for selecting community pharmacies. Prescriptions written by 
specialized physicians were collected and analyzed according to WHO standard 
treatment guidelines. RESULTS: The data were gathered from 896 prescriptions. 
Unfair number of drugs was prescribed in which the mean number of drugs in a 
single prescription was 4.0 (+1.8). The value of prescribing indicators was more 
than the WHO standard indicators. Most of the prescribed medicines (87%) have 
been written in their generic names. Moreover, the frequently prescribed 
medicines were antibiotics (45.7%); anxiolytics (19.3%); and corticosteroids (12%). 
CONCLUSIONS: Physicians’ adherence to the standard prescribing guidelines 
was poor in this study. Although the affordability of medicines was good; the 
practice of prescribing medicines need to be appropriate. Implementing 
appropriate administrative strategies to improve the current prescribing pattern 
in Basrah; as well as, patient-educational programs concerning the treatment 
they receive are warranted. In addition, further studies should be undertaken in 
other provinces of Iraq in order to understand the country level of prescribing 
medicines.  
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GREAT ROC! SO WHAT? BRINGING PREDICTIVE MODELING AND RISK SCORES 
INTO THE PHYSICIANS' OFFICE  
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OBJECTIVES: To develop and validate a 30-day readmission risk prediction model 
for implementation in a site-of-service personalized medicine tool. The 
readmission risk score (RRS) is easily interpretable by providers and adaptable to 
variability in input data. METHODS: The RRS was developed and validated using 
administrative claims linked to additional data for commercial and Medicare 
Advantage (MA) enrollees hospitalized between 01Jan2007 and 30Sep2011. Blocks 
of candidate predictors (demographics, comorbidities, social determinants of 
health, mental health conditions, pre-admission service utilization, admission 
details) were used in logistic regression predicting readmission. Main and 
interaction effects were examined within blocks and blocks were combined in 
step-wise fashion. Goodness-of-fit was assessed with Wald chi-square and c-
statistics. Sub-models for each combination of blocks accommodated variations 
in available data. The ROC distribution was used to create an indicator of the 
utility of each patients’ RRS: green for best predictive power, yellow, and red for 
predictive power too low for use by the care manager in prioritizing patient 
outreach. RESULTS: Overall 30-day readmission rate among hospitalized 
subjects (N=973,316, 53% female, mean age 55, 8% MA, 13% non-white, mean 
Charlson score: 1.66) was 7.5%. When subjects with a predicted RRS ≥ 0.10 were 
classified as ‘readmitted,’ model statistics were: c-statistic=0.6735, 
sensitivity=0.3801, specificity=0.8426. Sub-models were classified as having low, 
moderate, or best predictive ability (c-statistic ranges: 0.5644–0.6002; 0.6183–
0.6483; 0.6583–0.6725 respectively). CONCLUSIONS: The RRS achieved high 
specificity; sensitivity and overall c-statistic were not optimal. Predictive ability 
of the index may be improved in the next phase when both claims and electronic 
medical records data will be used to reconstruct the RRS. The RRS allows care 
systems to calculate a risk score at the site-of-service with even a minimum set 
of data. Providers are presented with the strength of the score so that they may 
apply limited resources with data-driven intelligence.  
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THE LOWEST-HANGING FRUIT: QUALITY METRICS AND COSTLY 
HOSPITALIZATIONS  
Bueller JA, Ringwelski M, Meyrowitz S, Bastian AW, Richardson SK 
GfK Bridgehead, San Francisco, CA, USA  
OBJECTIVES: In 2010, Medicare spent over $117 billion in hospital-related expenses. 
The new Accountable Care Organization (ACO) model promises to reduce some of 
these costs by allowing providers to financially benefit from any savings they can 
deliver while also maintaining strong quality with an eye towards prevention of 
costly hospitalizations. In the short-term, specifically the 3-year trial period, ACOs 
will need to prioritize their initiatives and target areas where they can be most 
successful and expedient in reducing costs. We aim to understand whether the 
CMS-mandated quality benchmarking has the potential to drive a reduction in 
common and costly hospitalizations through increased diagnostic tests, better care 
coordination, and management of patients with chronic diseases in the short-term. 
METHODS: This research examines the alignment between 1) the CMS-mandated 
ACO quality metrics, and 2) the most utilized and costly DRG codes (2010 MedPAR 
data). We also examine the evidence to support the possibility that a reduction in 
hospitalizations within these top DRG categories can be achieved. RESULTS: 
Analyses indicate that quality metrics are aligned and can drive reductions in 60% 
of the top 20 DRG claim categories. These costly DRGs include those for the 
treatment of chronic obstructive pulmonary disease, renal failure, heart failure, 
septicemia or severe sepsis, psychoses, and rehabilitation days after 
hospitalization. Together, these DRG claims cost Medicare over $21 billion in 
hospital-related expenses in 2010. CONCLUSIONS: If ACOs diligently work to 
achieve their quality benchmarks, they have the potential to deliver savings to CMS 
by reducing costs through better outpatient care and hospitalization prevention 
strategies within the top 20 DRG claim categories. However, it remains unclear as to 
what degree savings can be achieved.  
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THE BENEFITS OF HOSPITAL SPECIALIZATION: EFFECTS ON CLINICAL QUALITY 
AND FINANCIAL PERFORMANCE  
Petratos P1, Salge O2, Vera A3 
1Oxford University, Oxford, UK, 2Ruhr-University Bochum, Bochum, Germany, 3German Police 
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OBJECTIVES: It has been argued that medical specialization has positive benefits 
for health outcomes. The objective of this study is to assess whether or not 
specialized, single-service hospital organizations outperform generalist ones 
METHODS: We collected data from all 169 hospital organizations in England that 
admit adult inpatients. These were observed over two financial years (April 2005-
March 2007), producing a total of 338 observation points. Mean patient 
satisfaction scores were used to measure clinical quality, while financial 
performance was measured by Return on Assets (ROA). Random effects panel 
regression analysis with control variables was employed. RESULTS: It is observed 
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that a positive correlation exists in hospitals between service specialization and 
the level of clinical quality; furthermore, one also exists between clinical quality 
and financial performance. Finally, service specialization has a positive effect on 
financial performance, which is fully mediated by clinical quality. 
CONCLUSIONS: Based on a complete set of national data, this study 
demonstrates that hospital specialization has positive effects. Specialist hospital 
organizations provide superior quality of care and enhanced financial 
performance. Consequently, more specialization may prove to be a beneficial 
policy for the NHS.  
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PRE-MARKETING AUTHORIZATION OF NEW MEDICAL DEVICES IN THE 
EUROPEAN UNION AND THE UNITED STATES  
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OBJECTIVES: The European Union (EU) and the United States (US) have different 
regulatory systems for pre-marketing approval of medical devices (MDs) that 
result in differences in the MDs market authorizations and dates of market 
entry. This study analyzed differences between the MD regulatory systems in the 
US and the EU and evaluated the effect of those differences in pre-marketing 
authorization of new MDs in the period January 2000 to September 2012. 
METHODS: The study included a comparison of the regulation of MDs in the EU 
and the US and an analysis of MDs pre-marketing authorization dates in both 
systems in the period January 2000 to October 2012. Data were collected from the 
US Food and Drug Administration (FDA), companies’ webpages and a review of 
the literature. Descriptive statistics were used to compare differences in 
approval dates. Regression analysis was used to assess trends in differences in 
approval dates over the study period. RESULTS: There were important 
differences in pre-marketing approval systems for MDs between the US and the 
EU. More clinical information was required for approval of MDs in the US than in 
the EU. The FDA listed 514 new MDs approved in the study period. FDA pre-
marketing authorization and EU pre-marking authorization (i.e. CE mark) dates 
were available for 201 MDs. Approval of MDs occurred on average±stdev 
2.57±3.79 years earlier in the EU than in the US (median=2.42 years; 95%CI=1.86-
3.29 years). Overall, 171 MDs (85.1%) were authorized first in the EU. The 
difference in authorization dates grew over the study period at a rate of 
approximately 2.5 months per year. CONCLUSIONS: The EU and the US have 
different safety and efficacy regulatory requirements for MDs pre-marketing 
authorization. European patients have early access to new devices, whereas US 
patients have more MD-related information available for reimbursement and 
clinical decisions.  
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THE EFFECT OF MASSACHUSETTS HEALTH CARE REFORM ON INPATIENT AND 
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OBJECTIVES: The Commonwealth of Massachusetts implemented the first phase 
of a broad health care reform program from 2006 through 2008. The 
Massachusetts (MA) reform has increased insurance coverage and improved 
access to care. How the ACA will affect the hospital sector is undefined. The 
objectives of this study were to examine the effects of health care reform on 
inpatient services and emergency department visits in MA. METHODS: We used 
data from AHRQ's Healthcare Cost and Utilization Project (HCUP) State Inpatient 
Databases (SID) and the State Emergency Department Databases (SEDD). We 
implemented a difference-in-difference model to estimate the impact of the 
legislation and examined the changes between 2005 and 2009 in both MA and in 
control hospitals for a limited number of high-level indicators: discharges 
(overall and in selected categories); length of stay; cost per discharge; and 
emergency department (ED) visits and charges. We also estimated regression 
models that controlled for the hospital’s competitive environment for both the 
inpatient and ED variables. There were 64 MA hospitals with nonmissing values 
for all of the variables used in this study (62 with EDs). The control populations 
were propensity-score matched samples of hospitals drawn separately from the 
SID and the SEDD. RESULTS: Changes in inpatient utilization in MA were similar 
to those in other states. Length of stay declined more rapidly relative to the 
control sample (–6.0% versus –0.4%, respectively. The number of preventable 
hospitalizations for acute conditions declined in MA and the rest of the country. 
Hospitalizations associated with chronic conditions increased overall; results are 
at least suggestive that they rose faster in MA (0.05<p< 0.10). ED utilization grew 
in both groups, but ED charges per visit grew more slowly over the 5-year period 
in MA. CONCLUSIONS: Overall, the Massachusetts reform had modest effects on 
the hospital sector.  
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EXCHANGES  
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OBJECTIVES: Health insurance exchanges (HIX) are regulated, standardized 
online marketplaces that allow consumers to compare and purchase health 
insurance coverage. The U.S. Patient Protection and Affordable Care Act (2010) 
required all states and the District of Columbia to choose between establishing 
state-controlled HIX, either independently or through a state-federal 
partnership, or else defer to federally-controlled programs. Following a 
December 2012 decision deadline, 18 states and the District of Columbia opted to 
establish state-based programs, 7 states opted for partnership programs, and 25 
states defaulted to federally-controlled programs. The objective of this study was 
to examine variables associated with the adoption of federally-controlled HIX 
versus state-controlled and partnership HIX. METHODS: This descriptive, cross-
sectional study used publically available state-level data (n=51) from 2009 to 
2012. Information was obtained from sources such as the Kaiser Family 
Foundation and the Centers for Medicare and Medicaid Services. Chi-square 
analyses were performed on categorical variables in relation to federal versus 
state-controlled and partnership HIX and t-tests were used to compare means of 
continuous variables. RESULTS: 19 continuous and 5 categorical variables, 
including political, economic, and population health measures, were included in 
this analysis. Of these, political party of the governorship (p<0.001), 2012 
Electoral College result (p<0.01), decision regarding Medicaid expansion 
(p<0.001), unemployment rate (6.78% for federally-controlled HIX vs. 7.79% for 
state, p<0.05), and Medicaid enrollment in the <200% of Federal Poverty 
Guideline population (37.1% for federally-controlled HIX vs. 44.5% for state, 
p<0.05) were found to be significantly associated with default to federally-
controlled HIX. CONCLUSIONS: States that opted for, or defaulted to, federally-
controlled programs have shared political, economic, and population 
characteristics that may impact HIX design, implementation, and 
administration. Access to other state-level data may yield further significant 
findings.  
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OBJECTIVES: In France assessments by the Transparency Committee (TC) plays a 
significant role in pricing and market access of new products. TC evaluates 
clinical efficacy and safety data of new interventions, and compares it to current 
standard of care. TC’s assessments are made using ASMR ratings ranging from I 
to V (major innovation to no improvement). The objective of this study was to 
understand trends in TC’s assessments for new products approved by the EMA 
between 2011-2012. METHODS: TC’s assessments for 11 products approved by 
the EMA between 2011-2012 were analyzed for their ASMR ratings. Analysis was 
conducted to identify new trends and compare them for products based on their 
indications, comparators, and launch timing. RESULTS: Analysis of 2011-2012 
assessments by TC shows that the majority of products (73%) received an ASMR 
rating of IV (minor improvement). Approximately 27% of the products received 
an ASMR rating of III and V. A new trend in TC’s assessment is the assignment of 
two ASMR ratings for one product for different subgroups or patient line of 
treatment. During last one year 3 out of 11 products received two ASMR ratings. 
None of the products received ASMR ratings of I and II. The products that 
received ASMR rating of V (no improvement) were indicated for cardiovascular, 
epilepsy, and bone metastases. All assessments included analysis of 
intervention’s data versus one or more comparators. CONCLUSIONS: France TC’s 
assessments trends show a need for robust comparative effectiveness data to 
obtain better ASMR ratings, which affects both pricing and market access of new 
products. Future products would need subgroup analysis to obtain high ASMR 
ratings for all patient populations.  
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OBJECTIVES: In the pursuit of performance enhancement in the health care 
system in Egypt, particularly in the pharmaceutical sector, researchers face 
severe lack of relevant data. This limits our understanding of the health care 
system and the ability to detect policy-relevant problems. This is especially true 
for community pharmacies, which make the most easily accessible health care 
avenues for Egyptian households. We, therefore, sought to explore the 
characteristics of Egyptian community pharmacies in terms of labor force and 
practice patterns. METHODS: This is the first wave of a modified cross-sectional 
survey adapted from the US National Pharmacist Workforce Survey.  
We randomly sampled pharmacies located in the East and South regions of Cairo 
from addresses listed in Yellow Pages using a systematic random sampling 
methodology. Pharmacy data was collected through personal interviewing of the 
pharmacist on duty in the surveyed pharmacies. RESULTS: One-hundred- 
and-sixty-nine pharmacies participated in the survey (72% response rate). 
Independent pharmacies accounted for 88% of respondents. Only 35% of  
the pharmacies had a full time pharmacist, while 20% suffered recent layoffs  
of pharmacists. Virtually all pharmacies offered disease and medication 
counseling, 58% offered compounding services, 56% offered drug information 
services, and 40% carried durable medical equipments. Respondent pharmacists 
were on average 31.6 years old; 62% were male; the majority (94%) had only  
the bachelor's of pharmacy degree; work 56.3 hours per week; and receive  
6.05 Egyptian Pounds (EGP) (~ $1) per hour in compensation. Males reported 
working more weekly hours (58.8 vs. 52.4, p=0.02) but the average hourly  
rate was not statistically different from females (6.12 vs. 5.94 EGP, p=0.2). 
CONCLUSIONS: This study illustrates an ongoing effort to document  
